YANET MENENDEZ: Open Payments
NPI 1720569031 · CAPE CORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$689 in 37 payments from 13 companies in 2025. Trend: 2023 $1,235 · 2024 $1,128 · 2025 $689
Food & beverage: $689
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $145 |
| Vanda Pharmaceuticals Inc. | 4 | $98 |
| Janssen Pharmaceuticals, Inc | 4 | $96 |
| Neurocrine BioSciences, Inc. | 3 | $71 |
| Tris Pharma Inc | 4 | $62 |
| Lundbeck LLC | 3 | $53 |
| Supernus Pharmaceuticals, Inc. | 3 | $44 |
| Collegium Pharmaceutical, Inc. | 2 | $40 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
Products named: VRAYLAR, FANAPT, INGREZZA, Dyanavel XR, INVEGA SUSTENNA, REXULTI, Qelbree, Jornay PM.
Industry payments across FL — which companies pay providers there.
